Top Five Reasons the #1 Alternative to NSAIDs Makes Good Business Sense Independent pharmacies and healthcare providers expand business with AminoActiv reseller program
MADISON, Tenn., Jan. 22, 2013 /PRNewswire/ -- All across America, independent pharmacies and healthcare providers are on the frontlines of pain relief. Consumers and patients rely on the advice and expertise they receive from professionals on the ground locally to control pain and inflammation related to arthritis, muscle strain, joint and back injury, fibromyalgia, plantar fasciitis, headaches, menstrual cramps and more. Given the following facts, retailers and health practitioners bear a tremendous responsibility and opportunity in meeting consumer and patient needs:
- According to the American Pain Foundation, 75 million Americans suffer from pain, and that number will only increase as the population continues to age.
- 33 million people use NSAIDs regularly to treat their pain and inflammation.
- An extensive range of NSAID adverse effects, including gastrointestinal ailments, renal failure, and increased heart failure risk, has been documented worldwide.
- About 75 percent of pain sufferers do not comply with or seek adequate treatment because of fear of side effects or addiction.
- Despite an abundance of NSAID alternatives on the market, few are backed by reputable safety and efficacy studies.
These facts are not simply alarm bells for the retailers and professionals who are face to face with pain sufferers every day. They also represent a business opportunity for pharmacies and healthcare providers invested in offering an effective and safe pain relief option. That is the motivation behind a growing number of resellers who are now offering AminoActiv® (www.aminoactiv.com), the #1 alternative to ibuprofen and NSAIDs.
"People are becoming more aware of drug toxicities but available pain relief alternatives, including herbal remedies, holistic therapies, plant extracts and natural or home remedies, have proved inconsistent, often ineffective and sometimes unsafe," stated Mark Faulkner, president of Vireo Systems, the manufacturer of AminoActiv. "The exception is AminoActiv, a non-toxic, scientifically proven solution that doesn't just relieve pain but promotes healing."
As outlined in the first-ever ebook dedicated to resellers on the topic, AminoActiv is unlike other alternative options because medical studies actually demonstrate this medication's safety and efficacy. Available through Vireo System's website www.aminoactiv.com/businessopportunity, the AminoActiv ebook also presents the research-backed data that substantiates AminoActiv's unique ability to provide powerful, safe pain and inflammation relief while supporting restoration of damaged tissue. It also outlines the empirical data highlighting the dangers of ibuprofen and NSAIDs, plus the reasons behind the void in the marketplace for effective alternatives.
"With our AminoActiv ebook, resellers have all the information they need to help their patients make the switch to AminoActiv," Faulkner says. "Since AminoActiv offers a highly advantageous reseller program, medical and pharmacy professionals will appreciate promoting a product that provides peace of mind and makes good business sense. Retailers and practitioners who sell AminoActiv are very successful with it simply because it satisfies market demand safely and effectively."
To download the AminoActiv reseller ebook, go to www.aminoactiv.com/businessopportunity.
For more information on AminoActiv, visit www.aminoactiv.com.
About Vireo Systems, Inc.
Taking inspiration from one of the Latin words for "health," Vireo Systems, Inc. is the manufacturer of a number of health-related products including AminoActiv, the #1 alternative to ibuprofen and NSAIDs. Vireo was founded in 2002 as part of a project with several university-based researchers, and today, the company's products deliver safe, effective relief for inflammation and pain. Vireo meets industry-standard good manufacturing practices as expected by the FDA, and AminoActiv safety and toxicity data have been reviewed and accepted by the FDA.
Vireo is headquartered just outside Nashville, Tenn., with a secondary facility in Plattsmouth, Neb., where it manufactures its pain relief capsules and cream. Vireo is a two-time nominee for the NEXT Award, a prestigious honor celebrating successful businesses in the Middle Tennessee Region and part of an annual recognition program sponsored by the Nashville Area Chamber of Commerce and Entrepreneurial Center.
President, Vireo Systems, Inc.
This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.
SOURCE Vireo Systems, Inc.